IP Library Granted Patent US 7,964,343
Granted Patent B2
US 7,964,343 · App. 10/844,938 · Granted Jun 21, 2011

Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,964,343
App. No.
10/844,938
Granted
Jun 21, 2011
Kind
B2
Abstract

The present invention provides a method for rapid solution capture purification of nucleic acids for subsequent analysis by electrospray mass spectrometry which is efficient and cost-effective relative to existing methods. The present invention also provides kits useful for practicing rapid solution capture of nucleic acids so that purified samples are in condition for analysis by electrospray mass spectrometry.

Claims (29)

1. A method of purifying a solution comprising nucleic acids for mass spectrometry analysis comprising:

mixing said solution comprising nucleic acids with one or more magnetic beads linked to at least one anion exchange functional group having a pKa of 9 or greater to yield a suspension of said one or more magnetic beads in said solution wherein said nucleic acids bind to said at least one anion exchange functional group linked to said one or more magnetic beads;

isolating said one or more magnetic beads from said solution by application of a magnetic field;

removing said solution from said one or more magnetic beads;

washing said one or more magnetic beads to remove one or more contaminants with one or more wash buffers while said nucleic acids are bound to said at least one anion exchange functional group linked to said one or more magnetic beads; and

eluting said nucleic acids from said at least one anion exchange functional group linked to said one or more magnetic beads with an elution buffer compatible with electrospray ionization mass spectrometry wherein said elution buffer does not comprise a metal cation salt.

2. The method of claim 1 further comprising analyzing said nucleic acids by mass spectrometry.

3. The method of claim 1 wherein said mixing, washing, and eluting steps are performed by a liquid handler.

4. The method of claim 1 wherein said mixing, washing, isolating, and eluting steps are performed by a robot.

5. The method of claim 1 wherein said mixing is accomplished by pipetting, vortexing, sonication, or shaking.

6. The method of claim 1 wherein said one or more wash buffers comprises ammonium acetate.

7. The method of claim 1 wherein said one or more wash buffers comprises ammonium bicarbonate.

8. The method of claim 1 wherein said one or more wash buffers comprises methanol.

9. The method of claim 1 wherein said elution buffer comprises ammonium hydroxide.

10. The method of claim 1 wherein said elution buffer comprises piperidine, imidazole and methanol.

11. The method of claim 1 wherein said nucleic acids are the products of a nucleic acid amplification reaction.

12. The method of claim 11 wherein said nucleic acid amplification reaction is selected from the group consisting of polymerase chain reaction, ligase chain reaction or strand displacement amplification reaction.

13. The method of claim 1 wherein said one or more contaminants is selected from the group consisting of buffer additives, salts, detergents, polymers, stabilizers, metal cations, proteins and deoxynucleotide triphosphates.

14. The method of claim 6 wherein said one or more wash buffers comprise 50 mM to 200 mM ammonium acetate.

15. The method of claim 7 wherein said one or more wash buffer comprise 50 mM to 200 mM ammonium bicarbonate.

16. The method of claim 8 wherein said one or more wash buffer comprise 20% to 50% methanol.

17. The method of claim 9 wherein said elution buffer comprises 2% to 6% ammonium hydroxide.

18. The method of claim 10 wherein said elution buffer comprises 10 mM to 50 mM piperidine, 10 mM to 50 mM imidazole, and methanol.

19. The method of claim 18 wherein said methanol is selected from the group consisting of 30% methanol and 35% methanol.

20. The method of claim 18 wherein said elution buffer comprises 25 mM piperidine, 25 mM imidazole, and methanol.

21. The method of claim 20 wherein said methanol is selected from the group consisting of 30% methanol and 35% methanol.

22. The method of claim 1 , wherein said anion exchange functional group is polyethyleneimine.

23. The method of claim 1 , wherein said anion exchange functional group is a diethylaminomethyl.

24. The method of claim 1 , wherein said anion exchange functional group is a diethylaminoethyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: ISIS PHARMACEUTICALS, INC.
To: IBIS BIOSCIENCES, INC.
Reel/Frame 019691/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2004
From: HOFSTADLER, STEVEN A.; CUMMINS, LENDELL L.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 015143/0936 →